Results from the TAILORx study, which were presented at the American Society of Clinical Oncology meeting in Chicago and published in the New England Journal of Medicine, show that 70% of women with early-stage breast cancer can skip chemotherapy following the removal of their tumors. The results were from a study of the Oncotype DX test from Genomic Health (GHDX).
from RTT - Before the Bell https://ift.tt/2kQdsXW
via IFTTT
No comments:
Post a Comment